Login

Scholarship means a door of opportunity|Onsi Sawiris,Co-Founder and Managing Partner,HOF Capital 00:10:00

Share On Facebook Share On Twitter

Focuses on cloud-based technologies, fintech and enterprise SaaS.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Market Update: Navigating Recession Talk and Investment Strategies
00:10:00
The Investor on Tour - Q&A with Francis Van Eeckhout, CEO Deceuninck | Francis Van Eeckhout - CEO of Deceuninck
00:10:00
Interview with Comer Industries President and CEO Matteo Storchi | Matteo Storchi, CEO, Comer Industries SpACOM:MIL
00:10:00
Secrets of Cybersecurity Entrepreneurship|Zane Lackey,General Partner,Andreessen Horowitz
00:10:00
Presentation Transcript of Roxgold at the One-to-One Conference
00:10:00
CEO with Banyan Gold interview | Tara Christie, President & Chief Executive Officer, Banyan Gold Corp. (CS, IE)
00:10:00
Explore Career Opportunities with Us
00:10:00
Exploring Company Achievements: Insights on Water Tank Success and Future Prospects|LALIT DAMODAR MEHTA,Managing Director,Samrat Pharmachem Ltd.
00:10:00
Dividend Investing Insights: James Harries on Trojan Global Income Fund | James Harries - Fund Manager, Trojan Global Income
00:10:00
Jim Russo on Peloton, USMCA, the Fed, and U.S.-China Trade Tensions | James M. Russo , Founder , Altrius Capital Management Inc.
00:10:00
Shri Rajkumar Kamat Shares Insights on EP Biocomposites Ltd's BSE SME Listing | Shri Rajkumar Kamat, Chairman , EP Biocomposites Ltd.
00:10:00
Why You Should Hire Endowment Wealth Management as Your Investment Advisor | Robert L. Riedl, CEO , Endowment Wealth Management, Inc.

© 2026 Nehu